Randomised controlled trials versus real life practice in BPH. Introduction and concluding remarks

Complications of Synthetic Midurethral Slings: Is There a Relevant Discrepancy Between Observational Data and Clinical Trials?

European urology focus·2023

Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens.

Autonomic & autacoid pharmacology·2015

The effect of mirabegron on patient-related outcomes in patients with overactive bladder: the results of post hoc correlation and responder analyses using pooled data from three randomized Phase III trials.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2015

Tissue engineered buccal mucosa for urethroplasty: progress and future directions.

Advanced drug delivery reviews·2014

Contemporary issues with pharmacotherapy for lower urinary tract symptoms.

International journal of clinical practice·2014

Safety and tolerability of the β3 -adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trial.

International journal of clinical practice·2014

EORTC 2238 DE-ESCALATE: Revisiting Intermittent Maximal Androgen Blockade in Metastatic Hormone-sensitive Prostate Cancer.

European urology·2026

Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis.

European urology·2026

Cystectomy Can Be Spared in Selected Patients with Muscle-invasive Bladder Cancer and Complete Response Following Neoadjuvant Therapy.

European urology·2026

Systematic Review and Meta-analysis on Renal Tumor Biopsy: Accuracy, Safety, and Impact on Clinical Decision-making.

European urology·2026

What Comes After Matters: The Importance of Postprogression Care in Patients with Metastatic Hormone-sensitive Prostate Cancer.

European urology·2026

Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial.

European urology·2026

Long-Term Weight Regain Outcome Post-Bariatric Surgery: Key Influencing Factors.

Obesity surgery·2026

Clinicopathologic Spectrum of Sclerosing Microcystic Adenocarcinoma: A Systematic Review of Newly Classified Salivary Gland Malignancy.

Annals of maxillofacial surgery·2026

Short-term and long-term outcomes of non-tracheal intubation anesthesia in thoracoscopic lobectomy for lung cancer: A systematic review and meta-analysis.

Molecular and clinical oncology·2026

Clinical outcomes of medical therapy, EUS-guided ethanol ablation, and surgical resection in insulinoma: a clinical epidemiology study.

Frontiers in endocrinology·2026

Comparison of 2 approaches for left atrial myxoma excision: Outcomes and safety.

JTCVS techniques·2026

Autoimmune cholangiopathy presenting as a mimicker of hilar cholangiocarcinoma.

VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy·2026

Related Experiment Videos

Randomised controlled trials versus real life practice in BPH. Introduction and concluding remarks

Related Concept Videos

Complications of Synthetic Midurethral Slings: Is There a Relevant Discrepancy Between Observational Data and Clinical Trials?

Functional and radioligand binding characterization of the α1L-adrenoceptor subtype of the human vas deferens.

The effect of mirabegron on patient-related outcomes in patients with overactive bladder: the results of post hoc correlation and responder analyses using pooled data from three randomized Phase III trials.

Tissue engineered buccal mucosa for urethroplasty: progress and future directions.

Contemporary issues with pharmacotherapy for lower urinary tract symptoms.

Safety and tolerability of the β3 -adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12-week randomised Phase III trials and of a 1-year randomised Phase III trial.

EORTC 2238 DE-ESCALATE: Revisiting Intermittent Maximal Androgen Blockade in Metastatic Hormone-sensitive Prostate Cancer.

Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis.

Cystectomy Can Be Spared in Selected Patients with Muscle-invasive Bladder Cancer and Complete Response Following Neoadjuvant Therapy.

Systematic Review and Meta-analysis on Renal Tumor Biopsy: Accuracy, Safety, and Impact on Clinical Decision-making.

What Comes After Matters: The Importance of Postprogression Care in Patients with Metastatic Hormone-sensitive Prostate Cancer.

Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial.

Long-Term Weight Regain Outcome Post-Bariatric Surgery: Key Influencing Factors.

Clinicopathologic Spectrum of Sclerosing Microcystic Adenocarcinoma: A Systematic Review of Newly Classified Salivary Gland Malignancy.

Short-term and long-term outcomes of non-tracheal intubation anesthesia in thoracoscopic lobectomy for lung cancer: A systematic review and meta-analysis.

Clinical outcomes of medical therapy, EUS-guided ethanol ablation, and surgical resection in insulinoma: a clinical epidemiology study.

Comparison of 2 approaches for left atrial myxoma excision: Outcomes and safety.

Autoimmune cholangiopathy presenting as a mimicker of hilar cholangiocarcinoma.

Related Experiment Videos

Randomised controlled trials versus real life practice in BPH. Introduction and concluding remarks

Related Concept Videos

Related Articles